| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 4, 2025 | Jun 6, 2025 | Stagwell Inc | Director | Buy | 95.0 | +665,757 | 8.94% | ✗ | $2.9M |
| May 9, 2025 | May 13, 2025 | Stagwell Inc | Director | Buy | 90.0 | +200,903 | 2.77% | ✗ | $956.3K |
| Aug 7, 2024 | Aug 9, 2024 | Theravance Biopharma, Inc. | 10% Owner | Buy | 100.0 | +999,800 | 11.75% | ✗ | $7.8M |
| Jun 10, 2024 | Jun 11, 2024 | SYNOVUS FINANCIAL CORP | 10% Owner | Sell | 17.5 | -172,889 | -11.79% | ✗ | $4.4M |
| Jun 5, 2024 | Jun 7, 2024 | SYNOVUS FINANCIAL CORP | 10% Owner | Sell | 40.0 | -7,148 | -0.49% | ✗ | $180.3K |
| May 31, 2024 | Jun 4, 2024 | SYNOVUS FINANCIAL CORP | 10% Owner | Sell | 16.3 | -219,963 | -12.99% | ✗ | $5.5M |
| May 1, 2024 | May 3, 2024 | Theravance Biopharma, Inc. | 10% Owner | Buy | 100.0 | +1,499,124 | 21.38% | ✗ | $13.1M |
| Oct 20, 2023 | Oct 24, 2023 | SYNOVUS FINANCIAL CORP | 10% Owner | Buy | 48.8 | +560 | 0.03% | ✗ | $12K |
| Oct 12, 2023 | Oct 16, 2023 | SYNOVUS FINANCIAL CORP | 10% Owner | Buy | 65.0 | +4,514 | 0.27% | ✗ | $97.1K |
| Oct 9, 2023 | Oct 11, 2023 | SYNOVUS FINANCIAL CORP | 10% Owner | Buy | 60.0 | +2,910 | 0.17% | ✗ | $62.2K |
| Oct 2, 2023 | Oct 4, 2023 | SYNOVUS FINANCIAL CORP | 10% Owner | Buy | 65.0 | +3,466 | 0.21% | ✗ | $73.8K |
| Sep 27, 2023 | Sep 28, 2023 | SYNOVUS FINANCIAL CORP | 10% Owner | Buy | 75.0 | +12,196 | 0.73% | ✗ | $259.8K |
| Sep 22, 2023 | Sep 26, 2023 | SYNOVUS FINANCIAL CORP | 10% Owner | Buy | 85.0 | +26,222 | 1.60% | ✗ | $558.5K |
| Sep 19, 2023 | Sep 21, 2023 | SYNOVUS FINANCIAL CORP | 10% Owner | Buy | 100.0 | +243,014 | 17.35% | ✗ | $5.2M |
| Mar 10, 2023 | Mar 14, 2023 | Stagwell Inc | Director | Buy | 100.0 | +750,000 | 11.64% | ✗ | $5.1M |
| May 10, 2022 | May 12, 2022 | Stagwell Inc | Director | Buy | 100.0 | +644,452 | 11.15% | ✗ | $4.4M |
| Dec 3, 2021 | Dec 7, 2021 | Stagwell Inc | Director | Buy | 95.0 | +292,961 | 5.34% | ✗ | $2.4M |
| Nov 30, 2021 | Dec 2, 2021 | Stagwell Inc | Director | Buy | 95.0 | +450,000 | 8.94% | ✗ | $3.4M |